BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6130914)

  • 1. A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxyarylamine carcinogens as a function of urine pH, voiding interval, and resorption.
    Young JF; Kadlubar FF
    Drug Metab Dispos; 1982; 10(6):641-4. PubMed ID: 6130914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
    Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
    Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis.
    Kadlubar FF; Miller JA; Miller EC
    Cancer Res; 1977 Mar; 37(3):805-14. PubMed ID: 13929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repair synthesis of DNA induced by the urinary N-hydroxy metabolites of carcinogenic arylamines in urothelial cells of susceptible species.
    Wang CY; Morton KC; Lee MS
    Cancer Res; 1985 Jan; 45(1):221-5. PubMed ID: 3965133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an experimental model for studying bladder carcinogen metabolism using the isolated rat urinary bladder.
    Airoldi L; Bonfanti M; Magagnotti C; Fanelli R
    Cancer Res; 1987 Jul; 47(14):3697-700. PubMed ID: 3594434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental model for investigating bladder carcinogen metabolism using the isolated rat urinary bladder.
    Airoldi L; Bonfanti M; Magagnotti C; Fanelli R
    IARC Sci Publ; 1987; (84):159-61. PubMed ID: 3679358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis.
    Kadlubar F; Kaderlik RK; Mulder GJ; Lin D; Butler MA; Teitel CH; Minchin RF; Ilett KF; Friesen MD; Bartsch H
    Princess Takamatsu Symp; 1995; 23():207-13. PubMed ID: 8844812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ, species, and compound specificity in the metabolic activation of primary aromatic amines.
    Poupko JM; Radomski T; Santella RM; Radomski JL
    J Natl Cancer Inst; 1983 Jun; 70(6):1077-80. PubMed ID: 6574277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pH on nonenzymatic oxidation of phenylhydroquinone: potential role in urinary bladder carcinogenesis induced by o-phenylphenol in Fischer 344 rats.
    Kwok ES; Eastmond DA
    Chem Res Toxicol; 1997 Jul; 10(7):742-9. PubMed ID: 9250407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary bladder carcinogenesis with N-substituted aryl compounds: initiation and promotion.
    Cohen SM
    Natl Cancer Inst Monogr; 1981 Dec; (58):63-7. PubMed ID: 7341985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of induction of epithelial cell proliferation by sodium saccharin and sodium L-ascorbate in the urinary bladder of NCI-black-Reiter (NBR) male rats.
    Uwagawa S; Saito K; Okuno Y; Kawasaki H; Yoshitake A; Yamada H; Fukushima S
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):182-6. PubMed ID: 8048061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of synergy between weak carcinogens in the induction of bladder cancer in experimental animals and humans.
    Hicks RM; Chowaniec J
    Cancer Res; 1977 Aug; 37(8 Pt 2):2943-9. PubMed ID: 872124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and binding of benzo(a)pyrene and 2-acetylaminofluorene by short-term organ cultures of human and rat bladder.
    Moore BP; Hicks RM; Knowles MA; Redgrave S
    Cancer Res; 1982 Feb; 42(2):642-8. PubMed ID: 6275985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of urinary levels of the carcinogen, N-hydroxy-2-naphthylamine, and its N-glucuronide in the rat by control of urinary pH, inhibition of metabolic sulfation, and changes in biliary excretion.
    Kadlubar FF; Unruh LE; Flammang TJ; Sparks D; Mitchum RK; Mulder GJ
    Chem Biol Interact; 1981 Jan; 33(2-3):129-47. PubMed ID: 6257402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on different responses of rats' small intestine mucous membrane and bladder transitional epithelium in the same carcinogenic urine environment].
    Wu B; Pan C; Song G
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(20):1227-9. PubMed ID: 11825523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-glucuronidation of benzidine and its metabolites. Role in bladder cancer.
    Zenser TV; Lakshmi VM; Davis BB
    Drug Metab Dispos; 1998 Sep; 26(9):856-9. PubMed ID: 9733663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonic acid metabolism by human urothelial cells: implication in aromatic amine-induced bladder cancer.
    Zenser TV; Davis BB
    Prostaglandins Leukot Essent Fatty Acids; 1988; 31(3):199-207. PubMed ID: 3138699
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism and DNA adduct formation of 2-acetylaminofluorene by bladder explants from human, dog, monkey, hamster and rat.
    Schut HA; Daniel FB; Schenck KM; Loeb TR; Stoner GD
    Carcinogenesis; 1984 Oct; 5(10):1287-92. PubMed ID: 6488449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of dog bladder mucosa in the N-oxidation of arylamines.
    Brill E
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):73-84. PubMed ID: 841183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.